51
|
Davis CH, Bass BL, Lillemoe KD, Lee JE, Balch CM, Aloia TA. Reviewing the Review: Assessment of the Peer-Review Process in Surgical Journals. J Am Coll Surg 2017. [DOI: 10.1016/j.jamcollsurg.2017.07.829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
52
|
Are C, Coit DG, McMasters KM, Giuliano AE, Anderson BO, Balch CM, Pathak KA, Audisio RA, Rubio IT, Gonzalez-Moreno S, Mori M, Eguchi H, Savant D, Prasad BKCM, Cheema MA, Chaudhry ZA, Yang HK, Park DJ, Coimbra FJF, Quadros C, Said HM, Bargallo-Rocha JE. Global Forum of Cancer Surgeons: Declaration of Intent. Ann Surg Oncol 2017; 24:2429-2431. [PMID: 28676922 DOI: 10.1245/s10434-017-5951-y] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2017] [Indexed: 11/18/2022]
|
53
|
Lian B, Cui C, Zhou L, Song X, Zhang X, Wu D, Chi Z, Si L, Sheng X, Kong Y, Tang B, Mao LL, Wang X, Li SM, Dai J, Yan X, Bai X, Zheng N, Balch CM, Guo J. Multivariate analysis of prognostic factors among 706 mucosal melanoma patients. J Clin Oncol 2017. [DOI: 10.1200/jco.2017.35.15_suppl.9569] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
9569 Background: Mucosal melanoma is rare and associated with extremely poor prognosis. Little is known about its outcome and prognostic analysis. In this study, we evaluated prognostic factors among mucosal melanomas. Methods: The survival rates, Relapse Free Survival (RFS), Overall Survival (OS) and prognostic factors were compared for 706 mucosal melanomas at different anatomical sites. Results: Mucosal melanoma from nasal pharyngeal and oral (268 pts), upper and lower gastrointestinal (GI) (221 pts), gynecological and urological (196 pts) had a similar survival with a 1-y survival rate (88%, 83%, 86%), 2-y survival rate (66%, 57%, 61%), 5-y survival rate (27%, 16%, 20%), respectively. Multivariate analysis revealed that Depth of Invasion (p < 0.001), Lymph node metastases (p < 0.001), Distant metastases (p < 0.001) were three independent prognostic factors for OS among 706 pts. Anatomical site (p = 0.031), Depth of Invasion (p < 0.001), Lymph node metastases (p < 0.001) were three independent prognostic factors for RFS among 543 pts. KPS status, Depth of Invasion, Lymph node metastases, Distant metastases were independent factors for OS among nasal pharyngeal and oral pts. Depth of Invasion, Lymph node metastases, CKIT Mutation were independent factors for RFS among nasal pharyngeal and oral pts. Gender, Lymph node metastases, Distant metastases were independent factors for OS among GI pts. Gender, Depth of Invasion, Lymph node metastases were independent factors for RFS among GI pts. Lymph node metastases, Distant metastases were independent factors for OS among Gynecological and Urological pts. Depth of Invasion, Lymph node metastases were independent factors for RFS among Gynecological and Urological pts. Conclusions: This is the first prognostic analysis for mucosal melanoma with the largest sample size for the first time. with few exceptions, It revealed that Depth of Invasion, Lymph node metastases, Distant metastases were independent prognostic factors for OS, Depth of Invasion and Lymph node metastases were independent prognostic factors for RFS. These results should be incorporated into the establishment of stage system and design of future clinical trials involving patients with mucosal melanoma.
Collapse
|
54
|
Balch CM, Coit DG, Berman RS. 2015 James Ewing Lecture: The 75-Year History of the Society of Surgical Oncology—Part II: The Transitional Years (1966–1990). Ann Surg Oncol 2016; 23:358-64. [PMID: 26464191 DOI: 10.1245/s10434-015-4863-y] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2015] [Indexed: 11/18/2022]
|
55
|
Balch CM, Hoon DSB. Donald L. Morton, MD.... A Legendary Surgical Oncologist and Consummate Investigator. Crit Rev Oncog 2016; 21:3-5. [PMID: 27480997 DOI: 10.1615/critrevoncog.2016016918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
56
|
Balch CM, Poston GJ, Coit D, Audisio R. Training a new generation of surgeons worldwide who are also oncologists. Chin Clin Oncol 2016; 5:58. [DOI: 10.21037/cco.2016.07.02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2016] [Accepted: 06/20/2016] [Indexed: 11/06/2022]
|
57
|
Audisio RA, Balch CM. Why Can’t Surgeons Treat Older Patients the Same as Younger Patients? Ann Surg Oncol 2016; 23:4123-4125. [DOI: 10.1245/s10434-016-5459-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2016] [Indexed: 11/18/2022]
|
58
|
Bland KI, Rikkers LF, Lillemoe KD, Balch CM, Edmunds LH, Murie J, Warnock GL, Waddell JP, Weigelt JA, Büchler MW, Neoptolemos JP, Madoff RD, Gamelli R, Cameron J, Kelly K, Talamini M, Coran AG, Puri P, Bent AE, Rohrich RJ, McFadden D, Souba WW, Pruitt BA, Wechsler AS, Warshaw AL, Sarr M, MacFadyen BV, Cuschieri A, Park A, Swanstrom L, Arregui ME, Scott-Conner C, Sugerman HJ, Hunter JG, Lippert H, Hopt U. Consensus Statement on Mandatory Registration of Clinical Trials. Surg Innov 2016. [DOI: 10.1177/1553350607299716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
59
|
Balch CM, Klimberg VS, McMasters KM, Pawlik TM, Tanabe KK, Posner MC, Whippen D, Roh MS. Benchmarking the Scientific and Educational Impact of the Annals of Surgical Oncology. Ann Surg Oncol 2016; 23:2723-9. [PMID: 27334224 DOI: 10.1245/s10434-016-5270-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2016] [Indexed: 01/07/2023]
|
60
|
Balch CM, Poston GJ. Training a new generation of surgical oncologists worldwide. Lancet Oncol 2016; 17:700-701. [PMID: 27299262 DOI: 10.1016/s1470-2045(16)30153-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2016] [Accepted: 05/09/2016] [Indexed: 11/16/2022]
|
61
|
Liao N, Hunt KK, Balch CM. Management of invasive and non-invasive breast cancer in the United States and China. Chin Clin Oncol 2016; 5:30. [PMID: 27265301 DOI: 10.21037/cco.2016.05.02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2016] [Accepted: 05/10/2016] [Indexed: 11/06/2022]
|
62
|
Hoekstra HJ, Wobbes T, Heineman E, Haryono S, Aryandono T, Balch CM. Fighting Global Disparities in Cancer Care: A Surgical Oncology View. Ann Surg Oncol 2016; 23:2131-6. [PMID: 27038459 PMCID: PMC4889619 DOI: 10.1245/s10434-016-5194-3] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2015] [Indexed: 12/13/2022]
Abstract
Cancer is the second leading cause of death globally after cardiovascular disease. Long-term cancer survival has improved in the Western world due to early detection and the use of effective combined treatment modalities, as well as the development of effective immunotherapy and drug-targeted therapy. Surgery is still the mainstay for most solid tumors; however, low- and middle-income countries are facing an increasing lack of primary surgical care for easily treatable conditions, including breast, colon, and head and neck cancers. In this paper, a surgical oncology view is presented to elaborate how the Western surgical oncologist can take part in the ‘surgical fight’ against global disparities in cancer care, and a plea is made to strive for structural solutions, such as a partnership in surgical oncology training. The pros and cons of the use of eHealth and mHealth technologies and education programs for schools and the community are discussed as these create an opportunity to reach a large portion of the population in these countries, at low cost and with high impact.
Collapse
|
63
|
Johnson CD, Balch CM. Commentary. Abdom Radiol (NY) 2016; 41:391. [PMID: 26826085 DOI: 10.1007/s00261-015-0625-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
64
|
Balch CM, Coit DG, Berman RS. 2015 James Ewing Lecture: 75-Year History of the Society of Surgical Oncology-Part III: The Transformative Years (1991-2015). Ann Surg Oncol 2016; 23:1409-17. [PMID: 26822879 DOI: 10.1245/s10434-015-5011-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2015] [Indexed: 11/18/2022]
|
65
|
Johnson CD, Balch CM. Editor Note. Ann Surg Oncol 2016; 24:682. [PMID: 26801780 DOI: 10.1245/s10434-016-5094-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
66
|
Balch CM, Nelson H, Niederhuber JE. Limitations of prospective surgical oncology trials — a US view. Nat Rev Clin Oncol 2015; 13:6-8. [DOI: 10.1038/nrclinonc.2015.212] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
67
|
Ross MI, Balch CM. Excision Margins of Melanoma Make a Difference: New Data Support an Old Paradigm. Ann Surg Oncol 2015; 23:1053-6. [PMID: 26561402 DOI: 10.1245/s10434-015-4950-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2015] [Indexed: 11/18/2022]
|
68
|
|
69
|
Balch CM, Coit DG, Berman RS. 2015 James Ewing Lecture: The 75-Year History of the Society of Surgical Oncology-Part I: The Traditional Years (1940-1965). Ann Surg Oncol 2015; 23:16-22. [PMID: 26340862 DOI: 10.1245/s10434-015-4837-0] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2015] [Indexed: 11/18/2022]
|
70
|
Cavanaugh-Hussey MW, Mu EW, Kang S, Balch CM, Wang T. Older Age is Associated with a Higher Incidence of Melanoma Death but a Lower Incidence of Sentinel Lymph Node Metastasis in the SEER Databases (2003–2011). Ann Surg Oncol 2015; 22:2120-6. [DOI: 10.1245/s10434-015-4538-8] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2014] [Indexed: 11/18/2022]
|
71
|
Klimberg VS, Balch CM. The distinctive features of surgical oncology as a specialty: considerations for Chinese surgeons. Chin Clin Oncol 2015; 3:44. [PMID: 25841525 DOI: 10.3978/j.issn.2304-3865.2014.06.03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2014] [Accepted: 01/28/2015] [Indexed: 11/14/2022]
Abstract
In China, as in the United States and other countries, cancer patients will increasingly receive more than one modality of treatment delivered by cancer physicians from different medical specialties (e.g., internal medicine and surgery). In the United States and in many other countries, the surgical specialization, known as "surgical oncology" has grown as an essential part of cancer care delivery in the United States, both in academic medical centers and in the majority of cancer centers and hospitals in the local community. At a broad level, one can define the roles and responsibilities of a surgical oncologist as follows: (I) an excellent surgeon who can safely manage cancer patients through complex operations and have the judgment to know what operations to select; (II) knows how to integrate surgical treatment as part of a multidisciplinary team, including the type and timing of surgery after pre-operative systemic therapies and/or radiation therapies; (III) participates as an oncologist in the long-term disease-management of cancer patients; and (IV) participates in cancer clinical research and/or translational research. Perhaps the most compelling reason for surgical specializations is the evidence from multiple studies in the United States and Europe that "high volume" cancer centers and surgical specialists have better outcomes for treating complex or advanced cancers. It is important for all surgeons treating cancer patients to keep up to date with advances in oncology and be a partner with medical and radiation oncologists in providing contemporary multidisciplinary cancer care and to participate actively in cancer clinical trials where they are available. The uniqueness of our specialty is to function as both a surgeon and an oncologist in the management of the surgical patient with cancer.
Collapse
|
72
|
Balch CM. The value of multidiciplinary cancer care and research: the role of the surgeon as an oncologist and clinical investigator. Chin Clin Oncol 2015; 3:42. [PMID: 25841523 DOI: 10.3978/j.issn.2304-3865.2014.11.02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2014] [Accepted: 11/04/2014] [Indexed: 11/14/2022]
|
73
|
Balch CM. Decreased Survival Rates of Older-Aged Patients with Melanoma: Biological Differences or Undertreatment? Ann Surg Oncol 2015; 22:2101-3. [PMID: 25840561 DOI: 10.1245/s10434-015-4540-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2015] [Indexed: 11/18/2022]
|
74
|
Balch CM, Roh MS, Suzanne Klimberg V, Whippen DA. In memoriam: Donald L. Morton, MD (1934-2014): an icon in surgical oncology : past president, society of surgical oncology (1992-1993) and associate editor, annals of surgical oncology (1993-2014). Ann Surg Oncol 2014; 21:1413-6. [PMID: 24633667 DOI: 10.1245/s10434-014-3619-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
75
|
Balch CM, Roh MS, Whippen D, Suzanne Klimberg V. Annals of Surgical Oncology: the first 20 years. Ann Surg Oncol 2014; 21:3708-12. [PMID: 25216601 DOI: 10.1245/s10434-014-3937-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2014] [Indexed: 11/18/2022]
|